Evolva Holding SA Logo

Evolva Holding SA

0QQJ.L

(0.0)
Stock Price

0,86 CHF

-301.79% ROA

-139.43% ROE

-0.03x PER

Market Cap.

4.991.691,00 CHF

0% DER

0% Yield

-794.06% NPM

Evolva Holding SA Stock Analysis

Evolva Holding SA Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Evolva Holding SA Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

6 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Evolva Holding SA Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Evolva Holding SA Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Sell
4 Stoch RSI Sell

Evolva Holding SA Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Evolva Holding SA Revenue
Year Revenue Growth
2012 7.014.500
2013 8.706.200 19.43%
2014 10.744.300 18.97%
2015 13.363.600 19.6%
2016 9.575.700 -39.56%
2017 6.846.700 -39.86%
2018 8.932.600 23.35%
2019 11.596.000 22.97%
2020 7.540.700 -53.78%
2021 9.877.600 23.66%
2022 15.539.400 36.44%
2023 8.905.200 -74.5%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Evolva Holding SA Research and Development Expenses
Year Research and Development Expenses Growth
2012 19.459.200
2013 18.876.000 -3.09%
2014 23.025.500 18.02%
2015 35.019.500 34.25%
2016 33.026.300 -6.04%
2017 28.197.200 -17.13%
2018 18.585.000 -51.72%
2019 13.739.600 -35.27%
2020 13.555.600 -1.36%
2021 22.439.600 39.59%
2022 23.596.800 4.9%
2023 60.114.400 60.75%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Evolva Holding SA General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 6.869.600
2013 6.959.300 1.29%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Evolva Holding SA EBITDA
Year EBITDA Growth
2012 -16.683.800
2013 -14.311.400 -16.58%
2014 -19.004.900 24.7%
2015 -28.790.600 33.99%
2016 -33.965.100 15.23%
2017 -37.599.200 9.67%
2018 -23.351.400 -61.01%
2019 -13.429.900 -73.88%
2020 -18.166.000 26.07%
2021 -26.279.700 30.87%
2022 -16.568.000 -58.62%
2023 -15.398.800 -7.59%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Evolva Holding SA Gross Profit
Year Gross Profit Growth
2012 -12.444.700
2013 -10.169.800 -22.37%
2014 -13.405.300 24.14%
2015 -23.263.600 42.38%
2016 -26.402.000 11.89%
2017 2.148.500 1328.86%
2018 2.116.900 -1.49%
2019 5.291.500 59.99%
2020 -2.241.800 336.04%
2021 -9.305.900 75.91%
2022 -1.549.200 -500.69%
2023 -1.956.600 20.82%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Evolva Holding SA Net Profit
Year Net Profit Growth
2012 -16.005.199
2013 -15.731.900 -1.74%
2014 -21.352.900 26.32%
2015 -31.891.900 33.05%
2016 -35.970.700 11.34%
2017 -38.976.900 7.71%
2018 -29.213.900 -33.42%
2019 -21.638.900 -35.01%
2020 -29.870.200 27.56%
2021 -41.266.400 27.62%
2022 -43.366.400 4.84%
2023 -159.290.200 72.78%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Evolva Holding SA Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 -23
2013 -17 -35.29%
2014 -19 10.53%
2015 -23 13.64%
2016 -23 0%
2017 -20 -10%
2018 -9 -122.22%
2019 -7 -28.57%
2020 -9 22.22%
2021 -12 18.18%
2022 -10 -10%
2023 -35 71.43%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Evolva Holding SA Free Cashflow
Year Free Cashflow Growth
2012 -13.936.900
2013 -13.504.100 -3.2%
2014 -21.145.000 36.14%
2015 -33.593.800 37.06%
2016 -34.799.600 3.46%
2017 -36.163.200 3.77%
2018 -24.495.800 -47.63%
2019 -11.660.700 -110.07%
2020 -24.590.100 52.58%
2021 -30.124.500 18.37%
2022 -19.373.000 -55.5%
2023 -2.962.900 -553.85%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Evolva Holding SA Operating Cashflow
Year Operating Cashflow Growth
2012 -13.445.800
2013 -12.523.800 -7.36%
2014 -19.943.700 37.2%
2015 -31.729.200 37.14%
2016 -33.852.300 6.27%
2017 -35.572.900 4.84%
2018 -23.607.000 -50.69%
2019 -11.467.200 -105.87%
2020 -23.362.700 50.92%
2021 -29.789.200 21.57%
2022 -18.880.700 -57.78%
2023 -1.970.100 -858.36%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Evolva Holding SA Capital Expenditure
Year Capital Expenditure Growth
2012 491.100
2013 980.300 49.9%
2014 1.201.300 18.4%
2015 1.864.600 35.57%
2016 947.300 -96.83%
2017 590.300 -60.48%
2018 888.800 33.58%
2019 193.500 -359.33%
2020 1.227.400 84.23%
2021 335.300 -266.06%
2022 492.300 31.89%
2023 992.800 50.41%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Evolva Holding SA Equity
Year Equity Growth
2012 60.486.600
2013 83.281.200 27.37%
2014 174.993.700 52.41%
2015 203.415.600 13.97%
2016 173.056.600 -17.54%
2017 220.720.800 21.59%
2018 194.161.700 -13.68%
2019 172.562.100 -12.52%
2020 145.092.100 -18.93%
2021 131.770.299 -10.11%
2022 106.238.900 -24.03%
2023 28.816.400 -268.68%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Evolva Holding SA Assets
Year Assets Growth
2012 90.372.800
2013 105.272.400 14.15%
2014 212.611.600 50.49%
2015 232.236.600 8.45%
2016 198.235.500 -17.15%
2017 239.821.800 17.34%
2018 213.017.000 -12.58%
2019 192.078.100 -10.9%
2020 166.892.900 -15.09%
2021 156.173.400 -6.86%
2022 131.007.299 -19.21%
2023 53.137.000 -146.55%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Evolva Holding SA Liabilities
Year Liabilities Growth
2012 29.886.200
2013 21.991.200 -35.9%
2014 37.617.900 41.54%
2015 28.821.000 -30.52%
2016 25.178.900 -14.46%
2017 19.101.000 -31.82%
2018 18.855.300 -1.3%
2019 19.516.000 3.39%
2020 21.800.800 10.48%
2021 24.403.100 10.66%
2022 24.768.400 1.47%
2023 24.320.600 -1.84%

Evolva Holding SA Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
2.62
Net Income per Share
-20.81
Price to Earning Ratio
-0.03x
Price To Sales Ratio
0.42x
POCF Ratio
-0.34
PFCF Ratio
-0.44
Price to Book Ratio
0.11
EV to Sales
0.05
EV Over EBITDA
-0.04
EV to Operating CashFlow
-0.06
EV to FreeCashFlow
-0.05
Earnings Yield
-30.07
FreeCashFlow Yield
-2.27
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
54.6
Graham NetNet
-2.14

Income Statement Metrics

Net Income per Share
-20.81
Income Quality
0.1
ROE
-1.39
Return On Assets
-1.77
Return On Capital Employed
-0.56
Net Income per EBT
1
EBT Per Ebit
4.88
Ebit per Revenue
-1.63
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
2.8
Stock Based Compensation to Revenue
0.13
Gross Profit Margin
-0.53
Operating Profit Margin
-1.63
Pretax Profit Margin
-7.94
Net Profit Margin
-7.94

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-2.06
Free CashFlow per Share
-2.5
Capex to Operating CashFlow
0.21
Capex to Revenue
-0.17
Capex to Depreciation
-0.4
Return on Invested Capital
-0.67
Return on Tangible Assets
-3.02
Days Sales Outstanding
93.39
Days Payables Outstanding
69.46
Days of Inventory on Hand
435.23
Receivables Turnover
3.91
Payables Turnover
5.25
Inventory Turnover
0.84
Capex per Share
-0.44

Balance Sheet

Cash per Share
0,98
Book Value per Share
6,37
Tangible Book Value per Share
1.52
Shareholders Equity per Share
6.37
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0.3
Current Ratio
1.49
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
0
Working Capital
0,01 Bil.
Intangibles to Total Assets
0.41
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
15889000
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Evolva Holding SA Dividends
Year Dividends Growth

Evolva Holding SA Profile

About Evolva Holding SA

Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.

CEO
Mr. Christian Wichert
Employee
49
Address
Duggingerstrasse 23
Reinach, 4153

Evolva Holding SA Executives & BODs

Evolva Holding SA Executives & BODs
# Name Age
1 Thomas Schneckenburger C.F.A., Ph.D.
Head of Investor & Corporate Relations
70
2 Philipp Frech
General Counsel & Secretary of the Board
70
3 Ms. Astrid Schafer
Head of Research & Development
70
4 Mr. Christian Wichert
Chief Executive Officer
70
5 Mr. Carsten Daweritz
Chief Financial Officer
70
6 Mr. Gerhard Lobmaier
Chief Operations Officer
70
7 Ms. Anne De Vos
Chief Commercial Officer
70
8 Dr. Luc Gruner
Executive Officer
70

Evolva Holding SA Competitors

Evolva Holding SA Logo
Evolva Holding SA

EVE.SW

(0.5)
Microsaic Systems plc Logo
Microsaic Systems plc

MSYS.L

(1.0)
Oracle Power plc Logo
Oracle Power plc

ORCP.L

(1.0)